382 related articles for article (PubMed ID: 17134770)
1. Effect of free fatty acid inhibition on silent and symptomatic myocardial ischemia in diabetic patients with coronary artery disease.
Marazzi G; Wajngarten M; Vitale C; Patrizi R; Pelliccia F; Gebara O; Pierri H; Ramires JA; Volterrani M; Fini M; Rosano GM
Int J Cardiol; 2007 Aug; 120(1):79-84. PubMed ID: 17134770
[TBL] [Abstract][Full Text] [Related]
2. Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy.
Fragasso G; Piatti Md PM; Monti L; Palloshi A; Setola E; Puccetti P; Calori G; Lopaschuk GD; Margonato A
Am Heart J; 2003 Nov; 146(5):E18. PubMed ID: 14597947
[TBL] [Abstract][Full Text] [Related]
3. Effects of trimetazidine on myocardial perfusion and left ventricular systolic function in type 2 diabetic patients with ischemic cardiomyopathy.
Belardinelli R; Cianci G; Gigli M; Mazzanti M; Lacalaprice F
J Cardiovasc Pharmacol; 2008 Jun; 51(6):611-5. PubMed ID: 18574390
[TBL] [Abstract][Full Text] [Related]
4. Comparison of trimetazidine plus sildenafil to chronic nitrates in the control of myocardial ischemia during sexual activity in patients with coronary artery disease.
Rosano GM; Marazzi G; Patrizi R; Cerquetani E; Vitale C; Volterrani M; Fini M; Mercuro G
Am J Cardiol; 2005 Feb; 95(3):327-31. PubMed ID: 15670539
[TBL] [Abstract][Full Text] [Related]
5. Metabolic therapy for patients with diabetes mellitus and coronary artery disease.
Rosano GM; Vitale C; Fragasso G
Am J Cardiol; 2006 Sep; 98(5A):14J-18J. PubMed ID: 16931201
[TBL] [Abstract][Full Text] [Related]
6. The effects of trimetazidine on heart rate variability in patients with slow coronary artery flow.
Topal E; Ozdemir R; Barutcu I; Aksoy Y; Sincer I; Akturk E; Cehreli S
J Electrocardiol; 2006 Apr; 39(2):211-8. PubMed ID: 16580422
[TBL] [Abstract][Full Text] [Related]
7. Effect of trimetazidine on quality of life in elderly patients with ischemic dilated cardiomyopathy.
Marazzi G; Gebara O; Vitale C; Caminiti G; Wajngarten M; Volterrani M; Ramires JA; Rosano G; Fini M
Adv Ther; 2009 Apr; 26(4):455-61. PubMed ID: 19396409
[TBL] [Abstract][Full Text] [Related]
8. Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo-controlled study.
Rosano GM; Vitale C; Sposato B; Mercuro G; Fini M
Cardiovasc Diabetol; 2003 Nov; 2():16. PubMed ID: 14641923
[TBL] [Abstract][Full Text] [Related]
9. Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease.
Vitale C; Wajngaten M; Sposato B; Gebara O; Rossini P; Fini M; Volterrani M; Rosano GM
Eur Heart J; 2004 Oct; 25(20):1814-21. PubMed ID: 15474696
[TBL] [Abstract][Full Text] [Related]
10. Trimetazidine potentiates the effects of exercise training in patients with ischemic cardiomyopathy referred for cardiac rehabilitation.
Belardinelli R; Lacalaprice F; Faccenda E; Volpe L
Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):533-40. PubMed ID: 18797405
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of trimetazidine treatment on exercise tolerance and B-type natriuretic peptide and troponin T plasma levels in patients with stable ischemic cardiomyopathy.
Di Napoli P; Di Giovanni P; Gaeta MA; D'Apolito G; Barsotti A
Am Heart J; 2007 Sep; 154(3):602.e1-5. PubMed ID: 17719313
[TBL] [Abstract][Full Text] [Related]
12. Metabolic and endothelial effects of trimetazidine on forearm skeletal muscle in patients with type 2 diabetes and ischemic cardiomyopathy.
Monti LD; Setola E; Fragasso G; Camisasca RP; Lucotti P; Galluccio E; Origgi A; Margonato A; Piatti P
Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E54-E59. PubMed ID: 16174656
[TBL] [Abstract][Full Text] [Related]
13. Effect of 48-h intravenous trimetazidine on short- and long-term outcomes of patients with acute myocardial infarction, with and without thrombolytic therapy; A double-blind, placebo-controlled, randomized trial. The EMIP-FR Group. European Myocardial Infarction Project--Free Radicals.
Eur Heart J; 2000 Sep; 21(18):1537-46. PubMed ID: 10973768
[TBL] [Abstract][Full Text] [Related]
14. Does gastro-esophageal reflux provoke the myocardial ischemia in patients with CAD?
Dobrzycki S; Baniukiewicz A; Korecki J; Bachórzewska-Gajewska H; Prokopczuk P; Musial WJ; Kamiński KA; Dabrowski A
Int J Cardiol; 2005 Sep; 104(1):67-72. PubMed ID: 16137512
[TBL] [Abstract][Full Text] [Related]
15. Trimetazidine added to combined hemodynamic antianginal therapy in patients with type 2 diabetes: a randomized crossover trial.
Ribeiro LW; Ribeiro JP; Stein R; Leitão C; Polanczyk CA
Am Heart J; 2007 Jul; 154(1):78.e1-7. PubMed ID: 17584555
[TBL] [Abstract][Full Text] [Related]
16. The effects of chronic trimetazidine treatment on mechanical function and fatty acid oxidation in diabetic rat hearts.
Onay-Besikci A; Guner S; Arioglu E; Ozakca I; Ozcelikay AT; Altan VM
Can J Physiol Pharmacol; 2007 May; 85(5):527-35. PubMed ID: 17632588
[TBL] [Abstract][Full Text] [Related]
17. Comparison of trimetazidine with atenolol in patients with syndrome X: effects on diastolic function and exercise tolerance.
Leonardo F; Fragasso G; Rossetti E; Dabrowski P; Pagnotta P; Rosano GM; Chierchia SL
Cardiologia; 1999 Dec; 44(12):1065-9. PubMed ID: 10687257
[TBL] [Abstract][Full Text] [Related]
18. Effects of coronary artery disease and percutaneous intervention on the cardiac metabolism of nonesterified fatty acids and insulin: Implications of diabetes mellitus.
Jaumdally RJ; Lip GY; Patel JV; MacFadyen RJ; Varma C
J Intern Med; 2009 Jun; 265(6):689-97. PubMed ID: 19226374
[TBL] [Abstract][Full Text] [Related]
19. Acute effects of heparin administration on the ischemic threshold of patients with coronary artery disease: evaluation of the protective role of the metabolic modulator trimetazidine.
Fragasso G; Piatti PM; Monti L; Palloshi A; Lu C; Valsecchi G; Setola E; Calori G; Pozza G; Margonato A; Chierchia S
J Am Coll Cardiol; 2002 Feb; 39(3):413-9. PubMed ID: 11823078
[TBL] [Abstract][Full Text] [Related]
20. The anti-ischemic effect of trimetazidine in patients with postprandial myocardial ischemia is unrelated to meal composition.
Fragasso G; Montano C; Perseghin G; Palloshi A; Calori G; Lattuada G; Oggionni S; Bassanelli G; Locatelli M; Lopaschuk G; Margonato A
Am Heart J; 2006 Jun; 151(6):1238.e1-8. PubMed ID: 16781225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
